The most recent short interest data has been released for the 06/30/2017 settlement date, which shows a 1,046,512 share increase in total short interest for Acorda Therapeutics Inc (ACOR - Get Report), to 7,545,998, an increase of 16.10% since 06/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days (at the average volume) it would take to close out all of the open short positions if every share traded represented a short position being closed. Average daily volume for ACOR at the 06/30/2017 settlement decreased to 1,060,760, as compared to 1,284,631 at the 06/15/2017 report. That brought "days to cover" up to 7.11, a 40.60% increase from the 5.06 days to cover calculated at the previous short interest data release.The below chart shows the historical "days to cover" for ACOR at previous short interest release dates: An increased "days to cover" value could indicate that short sellers are using the stock to hedge a long bet elsewhere, or could also mean that short sellers believe the stock will decline in price. When short sellers eventually cover their positions, by definition there must be buying activity because a share that is currently sold short must be purchased to be covered. So investors tend to keep an eye on that "days to cover" metric, because a high value could predict a sharper price increase should the company put out some unexpectedly good news — short sellers might then rush to cover their positions, and if the "days to cover" number is high, it would then be more difficult to close those positions without sending the stock higher (until the higher price produces enough sellers to generate the necessary volume the short sellers need to close their positions). The chart below shows the one year performance of ACOR shares, versus its 200 day moving average. Looking at this chart, ACOR's low point in its 52 week range is $13.60 per share, with $33.00 as the 52 week high point — that compares with a last trade of $20.35. According to the ETF Finder at ETF Channel, ACOR makes up 3.45% of the PowerShares Dynamic Biotechnology & Genome Portfolio ETF (PBE) which is lower by about 0.7% on the day Thursday.
More from Stocks
Splunk Shares Higher as J.P. Morgan Upgrades Software Firm to Overweight
Analyst Mark Murphy has been bullish on Splunk's fundamentals for at least three quarters, but concern about valuation kept the firm neutral. After a cash-flow guide-down, the `Street consensus [is] largely derisked.'
Cracker Barrel Shares Climb on Earnings Beat, Positive Outlook
Same-restaurant sales rose 3.8% in the quarter, and expectations for fiscal 2020 are for growth of 2% to 3%.
Burlington and TJX Shares Higher After Analyst Upgrade; Other Retailers Lower
While tariffs have hit traditional retailers hard, they have provided a big opportunity for Burlington, which has seen market-share gains as shoppers seek out less expensive alternatives, according to UBS.
Bloom Energy Shares Slump After Scathing Short-Seller Report
Shares of Bloom Energy slumped after Hindenburg Research claimed to have found $2.2 billion in undisclosed liabilities.